Spark Investment Management LLC continued to hold its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 138,500 shares of the medical instruments supplier’s stock at the end of the second quarter. Spark Investment Management LLC’s holdings in AngioDynamics were worth $2,245,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of ANGO. Texas Permanent School Fund boosted its stake in shares of AngioDynamics by 0.6% in the first quarter. Texas Permanent School Fund now owns 23,129 shares of the medical instruments supplier’s stock worth $401,000 after buying an additional 145 shares during the period. Municipal Employees Retirement System of Michigan boosted its stake in shares of AngioDynamics by 3.0% in the first quarter. Municipal Employees Retirement System of Michigan now owns 7,200 shares of the medical instruments supplier’s stock worth $125,000 after buying an additional 210 shares during the period. Louisiana State Employees Retirement System boosted its stake in shares of AngioDynamics by 2.4% in the first quarter. Louisiana State Employees Retirement System now owns 13,000 shares of the medical instruments supplier’s stock worth $226,000 after buying an additional 300 shares during the period. Arizona State Retirement System boosted its stake in shares of AngioDynamics by 2.5% in the first quarter. Arizona State Retirement System now owns 16,596 shares of the medical instruments supplier’s stock worth $288,000 after buying an additional 400 shares during the period. Finally, Mason Street Advisors LLC boosted its stake in shares of AngioDynamics by 8.5% in the first quarter. Mason Street Advisors LLC now owns 7,470 shares of the medical instruments supplier’s stock worth $130,000 after buying an additional 584 shares during the period. 85.84% of the stock is currently owned by institutional investors and hedge funds.

Shares of AngioDynamics, Inc. (NASDAQ:ANGO) opened at 16.94 on Monday. The stock has a market cap of $620.92 million, a PE ratio of 89.16 and a beta of 1.15. The firm has a 50 day moving average price of $16.13 and a 200 day moving average price of $16.18. AngioDynamics, Inc. has a 12-month low of $14.80 and a 12-month high of $18.18.

AngioDynamics (NASDAQ:ANGO) last announced its quarterly earnings data on Tuesday, July 18th. The medical instruments supplier reported $0.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.16 by $0.03. AngioDynamics had a return on equity of 5.19% and a net margin of 2.00%. The business had revenue of $86.90 million for the quarter, compared to the consensus estimate of $90.72 million. During the same period in the previous year, the business earned $0.19 earnings per share. The business’s revenue was down 7.0% on a year-over-year basis. On average, equities analysts expect that AngioDynamics, Inc. will post $0.67 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/08/07/angiodynamics-inc-ango-position-held-by-spark-investment-management-llc.html.

A number of analysts recently issued reports on the company. Zacks Investment Research cut AngioDynamics from a “buy” rating to a “hold” rating in a report on Monday, April 10th. Cantor Fitzgerald increased their price objective on AngioDynamics from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, July 4th. Barclays PLC dropped their price objective on AngioDynamics from $17.00 to $16.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 19th. Canaccord Genuity reissued a “hold” rating and set a $17.00 price objective on shares of AngioDynamics in a report on Tuesday, July 18th. Finally, BidaskClub cut AngioDynamics from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Two research analysts have rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. AngioDynamics presently has a consensus rating of “Hold” and an average target price of $18.50.

In other AngioDynamics news, CEO James C. Clemmer acquired 20,000 shares of the stock in a transaction dated Thursday, July 20th. The shares were acquired at an average cost of $15.64 per share, for a total transaction of $312,800.00. Following the completion of the transaction, the chief executive officer now directly owns 86,683 shares of the company’s stock, valued at $1,355,722.12. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO James C. Clemmer acquired 5,000 shares of the stock in a transaction dated Friday, July 21st. The stock was acquired at an average price of $15.79 per share, for a total transaction of $78,950.00. Following the completion of the transaction, the chief executive officer now directly owns 86,683 shares of the company’s stock, valued at $1,368,724.57. The disclosure for this purchase can be found here. Insiders bought 25,316 shares of company stock worth $396,806 over the last 90 days. Company insiders own 1.88% of the company’s stock.

AngioDynamics Company Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.